| Ma Jerrylinn Ocampo Tanjutco, | |
|
808 W Main St, Battle Ground, WA 98604-9136 | |
| (360) 687-5136 | |
| (360) 687-5186 |
| Full Name | Ma Jerrylinn Ocampo Tanjutco |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 808 W Main St, Battle Ground, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184956112 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PH60022930 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ma Jerrylinn Ocampo Tanjutco, 808 W Main St, Battle Ground, WA 98604-9136 Ph: (360) 687-5136 | Ma Jerrylinn Ocampo Tanjutco, 808 W Main St, Battle Ground, WA 98604-9136 Ph: (360) 687-5136 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the "RNA Silencing: Mechanism, Biology, and Application" Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam's therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington's disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.
Herpes zoster, also known as shingles, is very rare among children who have been vaccinated against chicken pox, according to a Kaiser Permanente study in the December issue of the Pediatric Infectious Diseases Journal.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that a type of genetic material called "microRNA" plays surprisingly different roles in the formation of memory in animal models. In some cases, these RNAs increase memory, while others decrease it.
Genzyme Corporation announced today that it has entered into an agreement with Goldman, Sachs & Co. to repurchase $1 billion of Genzyme common stock under an accelerated stock repurchase program. Proceeds from its recently concluded debt offering will be used to support this first tranche of Genzyme's overall $2 billion share repurchase plan announced in May.
FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, will present the next generation of its cutting edge image processing technology, Dynamic Visualization II at the annual meeting of the Radiological Society of North America, from November 27 - December 2, 2016 at McCormick Center in Chicago, Illinois.
› Verified 6 days ago
Mr. Mark Stuhrman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Nw 12th Ave, Battle Ground, WA 98604 Phone: 360-666-5133 Fax: 360-666-5127 | |
Vitaliy Bejan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 W Main St, Battle Ground, WA 98604 Phone: 360-687-5133 | |
Amy E Delia, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 W Main St, Battle Ground, WA 98604 Phone: 360-687-5186 | |
Dr. Dori Ann Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17513 Ne 110th Ave, Battle Ground, WA 98604 Phone: 503-949-2591 | |
Hollie Kristin Williams, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 Nw 12th Ave, Battle Ground, WA 98604 Phone: 360-666-5133 Fax: 360-666-5127 | |
Benjy D Scurlock, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 W Main St Ste 115, Battle Ground, WA 98604 Phone: 800-813-2000 |